clinical medical device News
-
Forest Devices Announces $2.3 Million Seed Round
Forest Devices, Inc., a clinical-stage medical device company that is developing the first portable stroke screening technology, announced it has successfully closed an oversubscribed seed round of $2.3 million led by the GOOSE Society of Texas and other individual investors. The funding will be used to carry out a large multi-site clinical trial, further research and development, and business ...
-
Meagan Medical Inc. Announces Issuance of a Key U.S. Patent for a Disruptive Chronic Pain Treatment using Spinal Cord Stimulation
Patent provides protection for High Frequency Spinal Cord Stimulation with Beat Technology Vancouver, Washington – March 20, 2015 – Meagan Medical Inc., a clinical research and medical device development company focused on investigating and developing optimal ways of managing and controlling pain, announced today the issuance of a key patent related to a unique ...
-
Microbot Medical Achieves Significant Regulatory Milestone for the LIBERTY Robotic System; Files FDA Pre-Submission Package for Regulatory Pathway
HINGHAM, Mass., March 31, 2022 (GLOBE NEWSWIRE) -- The operational momentum that Microbot Medical Inc. (Nasdaq: MBOT) experienced at the end of 2021 has continued well into the 2022 first quarter. The Company filed its pre-submission package for the LIBERTY® Robotic System with the U.S. Food and Drug Administration (FDA), addressing the regulatory pathway for the LIBERTY® Robotic System. ...
-
Neurescue Announces Appointment of Medtronic Veteran Mette-Marie Harild to Company’s Board of Directors
COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a clinical-stage medical device company bringing to market the world’s first computer-aided balloon catheter for aortic occlusion, today announced that medical device industry veteran Mette-Marie Harild has been appointed to the Neurescue board of directors. Most recently the regional vice president of Medtronic’s largest sub-region in ...
By Neurescue
-
Liberate Medical’s VentFree Muscle Stimulator Receives Breakthrough Device Designation from the FDA to Reduce Mechanical Ventilation Duration
Liberate Medical, a clinical stage medical device company, focused on the development of novel non-invasive neuromuscular electrical stimulation devices to address pulmonary conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company’s VentFree muscle stimulator. The proposed indication for the device is preventing ...
-
ABK Biomedical Announces Enrollment Initiation of First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
ABK Biomedical, Inc., an innovative, clinical stage medical device company dedicated to the research, development and commercialization of advanced embolic therapies, announced the approval and initiation of a First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device, in collaboration with Auckland Hospital Research Unit, New Zealand. The prospective, single-center, ...
-
Liberate Medical Presents Data from its Pilot Trial of VentFree, a Muscle Stimulator for Mechanically Ventilated Patients, at the American Thoracic Society 2019 International Conference
Liberate Medical, a clinical-stage medical device company, developing novel electrical muscle stimulation devices that non-invasively address pulmonary conditions, today announced the results from its recently completed pilot trial of the VentFree Muscle Stimulator during an oral presentation at the American Thoracic Society International Conference (“ATS”) in Dallas, TX. ...
-
Microbot Medical to Present the Self-Cleaning Shunt at the 16th Asian Australasian Congress of Neurological Surgeons
HINGHAM, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company’s Self-Cleaning Shunt (SCS) at the 16th Asian Australasian Congress of Neurological Surgeons (AACNS). The AACNS is hosted by the Israel Neurosurgery Society and is being held from September 6th – 8th in Jerusalem, Israel. Dr Gustavo Rajz, Head of ...
-
Procyrion Names AV Edidin, Ph.D., as Senior Vice President of Development and Manufacturing
Procyrion, Inc., a clinical-stage medical device company developing the Aortix™ system, a percutaneous blood pump initially targeted for treating patients with heart failure and worsening kidney function (cardiorenal syndrome), announced the appointment of Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing. In this role, Edidin will lead and oversee product ...
-
Materials and application methods of disinfection and sterilization packaging
Paper or plastic "has a new meaning when it is related to the disinfection of instruments in dental clinics. As a medical device, there are strict standards for the production of sterilization packaging. Disinfection and sterilization bags are usually made of paper and plastic and are a key component of any sterility assurance. The goal of the dental infection control program is to reduce the ...
-
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
ABK Biomedical, Inc., an innovative, clinical-stage medical device company dedicated to the research, development and commercialization of advanced imageable embolic therapies, announced the first patient treated in ABK’s First-in-Human study with Eye90 microspheres™, a Y90 radioembolization device for the treatment of liver cancers. This study is being conducted in collaboration ...
-
Caliber Imaging & Diagnostics, Inc. Names Doug Leahy Vice President of Reimbursement and Health Economics
May 22, 2018—Boston, Mass.—Caliber Imaging & Diagnostics, Inc. (Caliber I.D.) announced today that Doug Leahy has joined the company as Vice President of Reimbursement and Health Economics to develop, lead and implement successful strategies for coverage, health policy and reimbursement of its VIVASCOPE® System. Mr. Leahy brings a strong emphasis and focus on physician ...
-
Gelmetix signs collaboration for development of Knee Osteoarthritis product
Stemmatters and Gelmetix have established an agreement to develop an innovative hydrogel based device for the treatment of cartilage lesions. The partnership established focuses on the pre-clinical development of the new device towards clinical studies in human patients and subsequent market authorization. The new medical device aims to ensure a significant advance in the treatment of ...
-
Hyalex Welcomes Chris Cain as VP of Clinical and Regulatory Affairs
Hyalex welcomes executive team member, Chris Cain, serving as Vice President of Clinical and Regulatory Affairs. Chris joins the Hyalex team with an impressive background in leading numerous clinical trials of implanted medical devices and taking innovative technologies through US PMA and international regulatory approvals. Chris provides the experience necessary to bring the HYALEX® ...
-
SetPoint Medical Appoints Amy Derosier as Vice President of Clinical Affairs
SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapies for chronic autoimmune diseases, today announced the appointment of Amy Derosier as Vice President of Clinical Affairs. “Amy’s extensive experience in successfully designing and executing clinical trials for novel medical devices complements that of our CMO, Dr. David Chernoff, who has extensive ...
-
Medovate Announces Us Distribution Agreement with Mercury Medical® For Safira®
Medovate has announced that it has entered into an agreement with Mercury Medical® for primary distribution of the FDA-cleared device SAFIRA® (SAFer Injection for Regional Anesthesia) across the whole of the United States (US). The agreement also includes the newly launched SAFIRA® Palm Operator which has been launched in the US market to offer anesthesiologists more versatility and ...
By Medovate
-
Advanced Bifurcation Systems Announces First Closing of Series A Financing
Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, is pleased to announce the first closing of an $11 million Series A equity financing. The round was led by Cedars-Sinai, an internationally renowned academic medical center, and by a leading ...
-
SANUWAVE Health Announces Expansion of Ametus Group Distribution Partnership
SANUWAVE Health, Inc. (OTCQB: SNWV), focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced today that the Company has entered into a non-exclusive sales and marketing agreement with Ametus to market and sell the Company’s portfolio of wound care products in ...
-
Soundbite Medical Announces Issuance Of A Fifth U.S. Patent Covering Novel Active Balloon Devices Intended For Plaque Modification Of Calcified Arteries
Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued US patent No. 11,179,169, entitled “Device for delivering mechanical waves through a balloon catheter”. The ...
-
Procyrion Raises $30 Million Series D to Support Clinical Trials of Its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients
Procyrion, Inc., a clinical-stage medical device company, today announced the completion of a $30 million Series D funding round led by a new investor, Bluebird Ventures. Returning investors include Fannin Partners, Scientific Health Development, the State of Texas, and an undisclosed strategic investor. The company is developing its Aortix™ system, a percutaneous blood pump initially ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you